SuviCa is pleased to announce that its co-founder and Chief Scientific Officer Dr. Tin Tin Su has been elected as a Senior Member by the National Academy of Inventors, for her impact on society through extraordinary innovation. https://www.colorado.edu/researchinnovation/2021/02/10/faculty-innovators-recognized-national-academy-inventors
A manuscript entitled ‘Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma’ and co-authored by SuviCa scientists Gomes, Frederick, Pronk, and Su is published Cancer Research, a journal of the American Association for Cancer Research. https://pubmed.ncbi.nlm.nih.gov/31911553/
SuviCa is pleased to announce that it received a 1.9M$ Phase II SBIR contract from the National Cancer Institute to develop a high throughput assay with a clonogenic endpoint that will be used to screen for novel radiation modulators of cancer.
SuviCa is pleased to announce that it presented at the Rocky Mountain Life Science Investor & Partnering Conference held October 2-3 at the Park Hyatt Hotel in Beaver Creek, Colorado. For full story see: http://www.cobioscience.com/RMLIPC/RMLIPC_Home.
Research by Professor Tin Tin Su, SuviCa’s co-founder and CSO, and Dr. Shilpi Verghese, CU Boulder post-doctoral fellow, was published in PLoS Genetics in an article titled “STAT, Wingless, and Nurf-38 determine the accuracy of regeneration after radiation damage in Drosophila”. Article Here: http://journals.plos.org/plosgenetics/article/comments?id=10.1371/journal.pgen.1007055
SuviCa is pleased to share the exciting news that SAB member and collaborator, Dr. Gail Eckhardt, has been named Associate Dean and Inaugural Director of the Livestrong Cancer Institutes of the Dell Medical School at the University of Texas at Austin. She will assume the position full time in January of 2017. Press release from […]
Research by Professor Tin Tin Su, SuviCa’s co-founder and CSO, and Dr. Shilpi Verghese, CU Boulder post-doctoral fellow, was published in PLoS Biology in an article titled “Drosophila Wnt and STAT Define Apoptosis-Resistant Epithelial Cells for Tissue Regeneration after Irradiation”. Article Here: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002536
SuviCa’s SAB member, Paul Bunn, received ASCO’s David Karnofsky Memorial Award for his lung cancer work. See: https://am.asco.org/2016-david-karnofsky-memorial-award-bestowed-upon-dr-paul-bunn-jr and http://www.coloradocancerblogs.org/cu-cancer-centers-paul-bunn-jr-md-fasco-earns-asco-david-karnofsky-memorial-award/
Co-Founder and CSO, Dr. Tin Tin Su interviewed on Colorado Public Radio’s Colorado Matters in story titled “In the ‘Moonshot’ Against Cancer, Where Does Colorado Stand?” For full story, click here: https://www.cpr.org/news/story/moonshot-against-cancer-where-does-colorado-stand.
CU biotech start-up gets $1.5 million contract to develop head and neck cancer treatment – See more at: http://www.colorado.edu/news/releases/2015/10/15/cu-biotech-start-gets-15-million-contract-develop-head-and-neck-cancer-treatment